Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Tuberculosis screening among persons with diabetes mellitus in Pune, India

Authors: Vidya Mave, Smita Nimkar, Haridas Prasad, Dileep Kadam, Sushant Meshram, Rahul Lokhande, Nikhil Gupte, Divyashri Jain, Amita Gupta, Jonathan E. Golub

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Diabetes mellitus (DM) increases tuberculosis (TB) risk, and there is increasing concern over the public health implications of the convergence of these two epidemics. Screening for TB among people with DM is now recommended in India.

Methods

People with DM seeking care at a large public sector tertiary care hospital clinic in Pune, India, were screened for TB from June 2015 to May 2016. All consenting people with DM were screened for TB at each clinic visit using a five-item, WHO-recommended questionnaire and those with TB symptoms and/or risk factors were tested for active TB using sputum smear microscopty, Xpert® MTB/RIF and TB culture. Categorical data and continuous variables were summarized using descriptive statistics. The x 2 test or Wilcoxon rank-sum test was used to ascertain significant associations between categorical and continuous variables, respectively.

Results

Among 630 adults approached for screening, median age was 60 (interquartile range (IQR), 57–64) years and 350 (56%) were females. Median hemoglobin A1c (HbA1c) was 8.7% (IQR, 6.7–9.9) and 444 (70.5%) were poorly controlled DM (HbA1c > 7). Forty-four (7%) had prior history of TB but the proportion with TB risk factors at screening was low (<5%). While 18% of participants reported any TB symptoms, none of these patients were diagnosed with culture confirmed TB.

Conclusions

Our study failed to yield any active TB cases using a WHO-recommended questionnaire among people with DM. High TB risk populations among people with DM must be identified if TB screening is to be feasible in settings such as India where the DM epidemic continues to rise.
Appendix
Available only for authorised users
Literature
2.
go back to reference Harries AD, Kumar AM, Satyanarayana S, et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop med Hyg. 2016;110(3):173–9.CrossRefPubMedPubMedCentral Harries AD, Kumar AM, Satyanarayana S, et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop med Hyg. 2016;110(3):173–9.CrossRefPubMedPubMedCentral
3.
go back to reference Odone A, Houben RM, White RG, Lonnroth K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014;2(9):754–64.CrossRefPubMed Odone A, Houben RM, White RG, Lonnroth K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014;2(9):754–64.CrossRefPubMed
4.
go back to reference Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS med. 2008;5(7):e152.CrossRefPubMedPubMedCentral Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS med. 2008;5(7):e152.CrossRefPubMedPubMedCentral
6.
go back to reference Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS. Diabetes and tuberculosis co-epidemic: the Bali declaration. Lancet Diabetes Endocrinol. 2016;4(1):8–10.CrossRefPubMed Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS. Diabetes and tuberculosis co-epidemic: the Bali declaration. Lancet Diabetes Endocrinol. 2016;4(1):8–10.CrossRefPubMed
7.
go back to reference World Health Organization IUATaLD. Collaborative framework for care and control of tuberculosis and diabetes. 2011. World Health Organization IUATaLD. Collaborative framework for care and control of tuberculosis and diabetes. 2011.
8.
9.
go back to reference Kornfeld H, West K, Kane K, et al. High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (EDOTS) study. Chest. 2016;149(6):1501–8.CrossRefPubMedPubMedCentral Kornfeld H, West K, Kane K, et al. High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (EDOTS) study. Chest. 2016;149(6):1501–8.CrossRefPubMedPubMedCentral
10.
go back to reference Nair S, Kumari AK, Subramonianpillai J, et al. High prevalence of undiagnosed diabetes among tuberculosis patients in peripheral health facilities in Kerala. Public Health Action. 2013;3(Suppl 1):S38–42.CrossRefPubMedPubMedCentral Nair S, Kumari AK, Subramonianpillai J, et al. High prevalence of undiagnosed diabetes among tuberculosis patients in peripheral health facilities in Kerala. Public Health Action. 2013;3(Suppl 1):S38–42.CrossRefPubMedPubMedCentral
11.
go back to reference Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367.CrossRefPubMedPubMedCentral Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367.CrossRefPubMedPubMedCentral
12.
go back to reference Screening of patients with tuberculosis for diabetes mellitus in India. Tropical medicine & international health: TM & IH 2013; 18(5): 636–45. Screening of patients with tuberculosis for diabetes mellitus in India. Tropical medicine & international health: TM & IH 2013; 18(5): 636–45.
13.
go back to reference Samal J. Screening of Tuberculosis patients for possible diabetes mellitus in India: a systematic review. The Egyptian journal of bronchology; 2017; 11: 1–6. Samal J. Screening of Tuberculosis patients for possible diabetes mellitus in India: a systematic review. The Egyptian journal of bronchology; 2017; 11: 1–6.
14.
go back to reference Screening of patients with diabetes mellitus for tuberculosis in India. Tropical medicine & international health: TM & IH 2013; 18(5): 646–54. Screening of patients with diabetes mellitus for tuberculosis in India. Tropical medicine & international health: TM & IH 2013; 18(5): 646–54.
15.
go back to reference Haraldsdottir TL, Rudolf F, Bjerregaard-Andersen M, et al. Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital Bissau. Trans R Soc Trop med Hyg. 2015;109(6):400–7.CrossRefPubMed Haraldsdottir TL, Rudolf F, Bjerregaard-Andersen M, et al. Diabetes mellitus prevalence in tuberculosis patients and the background population in Guinea-Bissau: a disease burden study from the capital Bissau. Trans R Soc Trop med Hyg. 2015;109(6):400–7.CrossRefPubMed
16.
go back to reference Majumder A, Carroll B, Bhana S, et al. Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa. The International Journal of Tuberculosis and Lung Disease. 2016;20(7):992–3.CrossRefPubMed Majumder A, Carroll B, Bhana S, et al. Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa. The International Journal of Tuberculosis and Lung Disease. 2016;20(7):992–3.CrossRefPubMed
18.
go back to reference Corbett EL, Zezai A, Cheung YB, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010;88(1):13–21.CrossRefPubMedPubMedCentral Corbett EL, Zezai A, Cheung YB, et al. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ. 2010;88(1):13–21.CrossRefPubMedPubMedCentral
19.
go back to reference Gil-Santana L, Almeida-Junior JL, Oliveira CA, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a retrospective cohort study. PLoS One. 2016;11(1):e0146876.CrossRefPubMedPubMedCentral Gil-Santana L, Almeida-Junior JL, Oliveira CA, et al. Diabetes is associated with worse clinical presentation in tuberculosis patients from Brazil: a retrospective cohort study. PLoS One. 2016;11(1):e0146876.CrossRefPubMedPubMedCentral
20.
go back to reference Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect dis. 2007;45(4):428–35.CrossRefPubMed Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect dis. 2007;45(4):428–35.CrossRefPubMed
21.
go back to reference Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–6.CrossRefPubMed Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–6.CrossRefPubMed
22.
go back to reference Heo EY, Choi NK, Yang BR, et al. Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus. Int J Tuberc Lung Dis. 2015;19(9):1098–101.CrossRefPubMed Heo EY, Choi NK, Yang BR, et al. Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus. Int J Tuberc Lung Dis. 2015;19(9):1098–101.CrossRefPubMed
Metadata
Title
Tuberculosis screening among persons with diabetes mellitus in Pune, India
Authors
Vidya Mave
Smita Nimkar
Haridas Prasad
Dileep Kadam
Sushant Meshram
Rahul Lokhande
Nikhil Gupte
Divyashri Jain
Amita Gupta
Jonathan E. Golub
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2483-9

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.